Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Epsilon Healthcare Limited ( (AU:EPN) ) just unveiled an update.
Epsilon Healthcare Limited has confirmed that all resolutions put to shareholders at its latest Annual General Meeting were passed by poll, signaling solid shareholder backing for the company’s current strategy and governance. The board highlighted the outcome as a vote of confidence from investors, which may support continuity in its diversified healthcare, pharmaceutical manufacturing, and pharmacy services operations as it pursues its broader growth objectives.
The most recent analyst rating on (AU:EPN) stock is a Hold with a A$0.03 price target. To see the full list of analyst forecasts on Epsilon Healthcare Limited stock, see the AU:EPN Stock Forecast page.
More about Epsilon Healthcare Limited
Epsilon Healthcare Limited is an Australian-based, globally active healthcare organisation that operates a diversified, vertically integrated portfolio of assets. Its business spans healthcare and clinic operations, pharmaceutical contract development and manufacturing, as well as pharmacy dispensing and information services, positioning the company across multiple points in the healthcare and pharmaceutical value chain.
YTD Price Performance: 45.83%
Average Trading Volume: 2,482,770
Technical Sentiment Signal: Buy
Current Market Cap: A$13.27M
See more insights into EPN stock on TipRanks’ Stock Analysis page.